Dr. Shpall on Therapeutic Agents for the Treatment of CLL

Elizabeth J. Shpall, MD, professor, deputy department chair, Department of Stem Cell Transplantation, Division of Cancer Medicine, medical director, Cell Therapy Laboratory, director, Cord Blood Bank, the University of Texas MD Anderson Cancer Center, discusses idelalisib and ibrutinib for the treatment of patients with chronic lymphocytic leukemia (CLL).

- See more at: onclive.com/onclive-tv/dr-s...

Jeff

oldestnewest

You may also like...